Skip to main content
Log in

Effects of vitamin D metabolites and analogs on bone collagen synthesis in vitro

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The effects of selected vitamin D3 metabolites and analogs on bone collagen synthesis in vitro were examined in organ cultures of neonatal mouse calvarial bone. The incorporation of [3H]proline into the collagenase-digestible fraction of newly synthesized protein was progressively inhibited by 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) (10−12 M to 10−7 M) in 24-h cultures, and incorporation into noncollagen protein was also blunted at the higher doses employed. The synthetic analog 1α-hydroxyvitamin D3 (1α-OHD3) was almost 300-fold less potent an inhibitor of collagen synthesis than was 1α,25(OH)2D3, and the natural metabolites 25-hydroxyvitamin D3 (25OHD3) and 24R,25-dihydroxyvitamin D3 (24R,25(OH)2D3), 1000-fold less potent, although the dose-response curve for each of these compounds was not parallel with that for 1α,25(OH)2D3. The 24S,25(OH)2D3 enantiomer was four-fold less potent than 24R,25-(OH)2D3 or 25OHD3, and vitamin D3 showed less than 2% the activity of 25OHD3. The responses were unaffected by the substitution of 0.4% bovine albumin for 5% horse serum in the medium, and no stimulation of collagen synthesis was observed in response to 25-hydroxylated metabolites between 2×10−14 and 2×10−6 M or in cultures treated for up to 96 h with 24R,25(OH)2D3 (2×10−10M).

The overall results emphasize the similarity of the structural requirements for the inhibition of matrix synthesis and the stimulation of resorption by active vitamin D metabolites in bone. In addition, these studies support the importance of the 1-hydroxyl function to the biologic activity of vitamin D in the skeleton.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carlsson, A.: Tracer experiments on the effect of vitamin D on the skeletal metabolism of calcium and phosphate, Acta Physiol. Scand.26:212–220, 1952

    Article  CAS  PubMed  Google Scholar 

  2. Tanaka, Y., DeLuca, H. F.: Bone mineral mobilization activity of 1,25-dihydroxycholecalciferol, a metabolite of vitamin D, Arch. Biochem. Biophys.146:574–578, 1971

    Article  CAS  PubMed  Google Scholar 

  3. Holick, M. F., Garabedian, M., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats, Science176:1146–1147, 1972

    CAS  PubMed  Google Scholar 

  4. Garabedian, M., Tanaka, M., Holick M. F., DeLuca, H. F.: Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxy-vitamin D3 in thyroparathyroidectomized rats, Endocrinology94:1022–1027, 1974

    CAS  PubMed  Google Scholar 

  5. Thomassett, M., Redel, J., Marche, P., Cuisinier-Gleizes, P.: Duodenal calcium-binding protein (CaBP) and bone calcium mobilization in response to 24R,25-and 24S,25-dihydroxycholecalciferol in intact and nephrectomized rats, J. Steroid Biochem.9:159, 1978

    Article  Google Scholar 

  6. Steenbock, H., Herting, D. C.: Vitamin D and growth, J. Nutr.57:449–468, 1955

    CAS  PubMed  Google Scholar 

  7. Canas, F., Brand, J. S., Neuman, W. F., Terepka, A. R.: Some effects of vitamin D3 on collagen synthesis in rachitic chick cortical bone, Am. J. Physiol.216:1092–1096, 1969

    CAS  PubMed  Google Scholar 

  8. Baylink, D., Stauffer, M., Wergedal, J., Rich, C.: Formation, mineralization and resorption of bone in vitamin D-deficient rats, J. Clin. Invest49:1122–1134, 1970

    CAS  PubMed  Google Scholar 

  9. Tanaka, Y., DeLuca, H. F.: Role of 1,25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets, Proc. Natl. Acad. Sci. U.S.A.71:1040–1044, 1974

    CAS  PubMed  Google Scholar 

  10. Russell, J. E., Avioli, L. V.: 25-Hydroxycholecalciferolenhanced bone maturation in the parathyroprivic state, J. Clin. Invest.56:792–798 1975

    Article  CAS  PubMed  Google Scholar 

  11. Raisz, L. G., Trummel, C. L., Holick, M. F., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture, Science175:768–769, 1972

    CAS  PubMed  Google Scholar 

  12. Reynolds, J. J., Holick, M. F., DeLuca, H. F.: The role of vitamin D metabolites in bone resorption, Calcif. Tissue Int.12:295–301, 1973

    Article  CAS  Google Scholar 

  13. Reynolds, J. J., Holick, M. F., DeLuca, H. F.: The effects of vitamin D analogues on bone resorption, Calcif. Tissue Int.15:333–339 1974

    Article  CAS  Google Scholar 

  14. Stern, P. H., DeLuca, H. F., Ikekawa, N.: Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3, Biochem. Biophys. Res. Commun.67:965–971, 1975

    Article  CAS  PubMed  Google Scholar 

  15. Stern, P. H., Trummel, C. L., Schnoes, H. K., DeLuca, H. F.: Bone resorbing activity of vitamin D metabolites and congenersin vitro: influence of hydroxyl substituents in the A ring. Endocrinology97:1552–1558, 1975

    CAS  PubMed  Google Scholar 

  16. Stern, P. H., Mavreas, T., Trummel, C. L., Schnoes, H. K., DeLuca, H. F.: Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bonesin vitro, Mol. Pharmacol.12:879–886, 1976

    CAS  PubMed  Google Scholar 

  17. Mahgoub, A., Sheppard, H.: Effect of hydroxy-vitamin D3 derivatives on45Ca release from rat fetal bonesin vitro, Endocrinology100:629–634 1977

    Article  CAS  PubMed  Google Scholar 

  18. Herrmann-Erlee, M. P. M., Gaillard, P. J.: The effects of 1,25-dihydroxycholecalciferol on embryonic bonein vitro: a biochemical and histological study, Calcif. Tissue Int.25:111–119, 1978

    Article  CAS  Google Scholar 

  19. Wong, G. L., Luben, R. A., Cohn, D. V.: 1,25-Dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells, Science197:663–665 1977

    CAS  PubMed  Google Scholar 

  20. Adams, J. S., Wong, G. L.: Lack of 24,25 dihydroxyvitamin D3 on isolated bone cells, Calcif. Tissue Int.28:172, 1979

    Google Scholar 

  21. Raisz, L. G., Maina, D. M., Gworek, S. C., Dietrich, J. W., Canalis, E. M.: Hormonal control of bone collagen synthesisin vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites, Endocrinology102:731–735, 1978

    CAS  PubMed  Google Scholar 

  22. Bordier, P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., Ryckwaert, A.: Vitamin D metabolites and bone mineralization in man, J. Clin. Endocrinol. Metab.46:284–294, 1978

    CAS  PubMed  Google Scholar 

  23. Bordier, P., Zingraff, J., Gueris, J., Jungers, P., Marie, P., Pechet, M., Rasmussen, H.: The effect of 1α OH D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy, Am J. Med.64:101, 1978

    Article  CAS  PubMed  Google Scholar 

  24. Kanis, J. A., Cundy, T., Bartlett, M., Smith, R., Heynen, G., Warner, G. T., Russell, R. G. G.: Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Br. Med. J.1:1382, 1978

    Article  CAS  PubMed  Google Scholar 

  25. Lieberherr, M., Pezant, E., Garabedian, M., Balsan, S.: Phosphatase content of rat calvaria afterin vitro administration of vitamin D3 metabolites, Calcif. Tissue Int.23:235–239, 1977

    Article  CAS  Google Scholar 

  26. Corvol, M. T., Dumontier, M. F., Garabedian, M., Rappaport, R.: Vitamin D and cartilage. II. Biological activity of 25-hydroxycholecalciferol and 24,25-and 1,25-dihydroxycholecalciferols on cultured growth plate chondrocytes, Endocrinology102:1269–1274, 1978

    CAS  Google Scholar 

  27. Ornoy, A., Goodwin, D., Noff, D., Edelstein, S.: 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation, Nature276:517–519, 1978

    Article  CAS  PubMed  Google Scholar 

  28. Dziak, R.: Effects of vitamin D3 metabolites on bone cell calcium transport, Calcif. Tissue Int.26:65–70, 1978

    Article  CAS  Google Scholar 

  29. Biggers, J. D., Gwatkin, R. B. L., Heyner, S.: Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined medium, Exp. Cell Res.25:41–58, 1961

    Article  CAS  PubMed  Google Scholar 

  30. Dietrich, J. W., Canalis, E. M., Maina, D. M., Raisz, L. G.: Hormonal control of bone collagen synthesisin vitro: effects of parathyroid hormone and calcitonin, Endocrinology98:943–949, 1976

    CAS  PubMed  Google Scholar 

  31. Peterkofsky, B., Diegelmann, R.: Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins, Biochemistry10:988–993, 1971

    Article  CAS  PubMed  Google Scholar 

  32. Peterkofsky, B.: The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblasts, Arch. Biochem. Biophys.152:318, 1972

    Article  CAS  PubMed  Google Scholar 

  33. McArthur, J. W., Colton, T. (eds.): Statistics in Endocrinology. MIT Press, Cambridge, Mass., 1970

    Google Scholar 

  34. Taylor, C. M., Hann, J., St. John, J., Wallace, J. E., Mawer, E. B.: 1,25-Dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D3, Clin. Chim. Acta96:1–8, 1979

    Article  CAS  PubMed  Google Scholar 

  35. Belsey, R., DeLuca, H. F., Potts, J. T., Jr.: Competitive binding assay for vitamin D and 25-OH vitamin D, J. Clin. Endocrinol. Metab.33:554–557, 1971

    Article  CAS  PubMed  Google Scholar 

  36. Peck, W. A., Dowling, I.: Failure of 1,25-dihydroxycholecalciferol [1,25-(OH)2-D3] to modify cyclic AMP levels in parathyroid hormone-treated and untreated bone cells, Endocrine Res. Commun.3:157–166, 1976

    Article  CAS  Google Scholar 

  37. Kream, B. E., Rowe, D. W., Gworek, S. C., Raisz, L. G.: Insulin and parathyroid hormone alter collagen-synthesis and procollagen messenger-RNA levels in fetal rat bone in vitro, Calcif. Tissue Int.28:148, 1979 (Abstr.)

    Google Scholar 

  38. Procsal, D. A., Okamura, W. H., Norman, A. W.: Structural requirements for the interaction of 1α,25-(OH)2-vitamin D3 with its chick intestinal receptor system, J. Biol. Chem.250:8382–8388, 1975

    CAS  PubMed  Google Scholar 

  39. Kream, B. E., Jose, M., Yamada, S., DeLuca, H. F.: A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone, Science197:1086–1088, 1977

    CAS  PubMed  Google Scholar 

  40. Chen, T. L., Hirst, M. A., Feldman, D.: A receptor-like binding macromolecule for 1α,25-dihydroxycholecalciferol in cultured mouse bone cells, J. Biol. Chem.254:7491–7493, 1979

    CAS  PubMed  Google Scholar 

  41. Cooke, N. E., Walgate, J., Haddad, J. G., Jr.: Human serum binding protein for vitamin D and its metabolites. II. Specific, high-affinity association with a protein in nucleated tissue, J. Biol. Chem.254:5965–5971, 1979

    CAS  PubMed  Google Scholar 

  42. Canalis, E. M., Hintz, R. L., Dietrich, J. W., Maina, D. M., Raisz, L. G.: Effect of somatomedin and growth hormone on bone collagen synthesisin vitro, Metabolism26:1079–1087, 1977

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bringhurst, F.R., Potts, J.T. Effects of vitamin D metabolites and analogs on bone collagen synthesis in vitro. Calcif Tissue Int 34, 103–110 (1982). https://doi.org/10.1007/BF02411216

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02411216

Key words

Navigation